HIGHLIGHTS
- who: Thomas Broggini and colleagues from the Department of Neurosurgery, University Hospital Frankfurt, Frankfurt am Main, Germany have published the article: Endothelial EphrinB2 Regulates Sunitinib Therapy Response in Murine Glioma, in the Journal: Life 2022, 12, 691. of 11/04/2022
- what: The authors aimed to research additive anti-tumor effects of genetic ephrinB2 depletion and antiangiogenic therapy.
- how: This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
- future: Further research is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.